Welcome to Prism!

Upload scholarly work, create communities, get citable links and more. To get the most out of Prism, log in with your NetID and check out our guide.

Published 2013 | Version v1.0.0
Journal Article Open

Immunomodulatory Therapy for Rasmussen Syndrome


Investigators from the National Epilepsy Center, Shizuoka, Gifu University, Tokyo Womens Medical University, National Center of Neurology and Psychiatry, and Okayama University School of Medicine, Japan, examined seizure, cognitive, and motor outcomes in 49 patients referred with Rasmussen encephalitis (RS) and recently had received initial immunomodulatory therapy: regular IV immunoglobulin (IVIg) at a dose of 100 mg/kg/day, methylprednisolone steroid pulse therapy at a dose of 30 mg/kg/day (children) for 3 days, and tacrolimus 0.1 mg/kg/day.


Files (94.3 kB)
Name Size Download all
94.3 kB Preview Download

Additional details

March 30, 2023
March 30, 2023